Supporters of the new push to legalize medical marijuana in Ohio have added several new medical conditions to a proposed constitutional amendment, including chronic traumatic encephalopathy, or CTE.
WeedLife News Network
Hot off the press cannabis, marijuana, cbd and hemp news from around the world on the WeedLife Social Network.
Supporters of the new push to legalize medical marijuana in Ohio have added several new medical conditions to a proposed constitutional amendment, including chronic traumatic encephalopathy, or CTE.
HARRISBURG, Pa. (WHTM) – The Pennsylvania House of Representatives is scheduled to take up a bill to legalize medical marijuana. The bill has been stalled in the House since it overwhelmingly passed the Senate last May.
BILLINGS - The battleground for medical marijuana in Montana is back, with both sides fired up, making their case to voters as signatures for initiatives are due in June.
With companies marketing drugs directly to consumers promising cures for almost anything, an increasingly destigmatized cannabis seems a likely target for the industry’s next game-changing medicine.
Oregon should fund an independent marijuana institute to support and conduct world-class research into the drug's medical and public health benefits, says a task force that includes state officials, scientists and leading physicians.
Marijuana can be used to effectively treat people suffering from migraine headaches, new research has found.
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.
BOSTON – A group of U.S. senators, including Elizabeth Warren and Ed Markey of Massachusetts, is still seeking answers on federal barriers to research on medical marijuana and hit U.S. agencies for a lack of coordination with states on the issue. Warren, Markey and six other senators sent a letter in July asking for information on federal agencies' efforts on medical marijuana research.
In a strongly-worded new report out Tuesday, researchers at the Brookings Institution call on the federal government to eliminate roadblocks to medical marijuana research in the U.S.
Nearly half the country has so far made it legal. Does it work?
Kesi Asher ~ JamaicaObserver.com ~
Canadian company to develop medicinal products from Jamaican marijuana for international market.
Howard Fischer, Capitol Media Services ~ azdailysun.com ~
PHOENIX -- If some Arizona nurses get their way, medical marijuana will become available as early as next year to treat everything from arthritis and autism to Tourette's syndrome and traumatic brain injury.
More U.S. college students are making a habit of using marijuana, which has supplanted cigarettes as the smoke-able substance of choice among undergraduates who light up regularly, a study released Tuesday found.
Jayson Chesler and Alexa Ard, News21 ~ via USAToday.com ~
Research on marijuana’s potential for medicinal use has been hampered for years by federal restrictions, even though nearly half of the states and the District of Columbia have legalized medical marijuana in some form.
With the widespread availability of marijuana in recent years thanks to its legalization in a growing number of states, there has been increasing concern about the long-term health consequences on teens who might be able to get easier access to it illegally.
People with a variety of medical ailments are leaving Texas for treatment in Colorado.
Andrew M. Seaman ~ Reuters ~
Moderate- or high-quality evidence supports the use of marijuana for some medical conditions, but not for others, according to a fresh review of past research.
Copyright 2019 - 2023. WeedWorthy.com is a news division of MjLink.com, Inc.. All rights reserved. WeedWorthy
To contact the following departments, dial 1-844-420-4208 - Sales: Ext. #2 - Support: Ext. #3 - Investor Relations: Ext. #6
By using this website, you agree and understand that, by law: You MUST be at least 21 years of age to view any content on this website. To view the complete Terms of Use and Privacy Policy for this website, Click Here!
